Spread | 0.55 | ||||
Long position overnight fee Long position overnight fee
Trade size with leverage ~ £5,000.00 Short position overnight fee ~ £4,000.00 | -0.025295% | ||||
Short position overnight fee Short position overnight fee
Trade size with leverage ~ £5,000.00 Short position overnight fee ~ £4,000.00 | 0.003377% | ||||
Overnight fee time | 21:00 (UTC) | ||||
Currency | GBP | ||||
Min traded quantity | 1 | ||||
Margin | 20 | ||||
Stock exchange | United Kingdom of Great Britain and Northern Ireland | ||||
Commission on trade1 | 0% |
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
Prev. Close | 45.85 |
Open | 46 |
1-Year Change | -34% |
Day's Range | 46 - 46.25 |
Croda International PLC is a United Kingdom-based specialty chemicals company. The Company's marketing and research activities are organized into four global market sectors: Personal Care, Life Sciences, Performance Technologies and Industrial Chemicals. Its Personal Care sector focuses on ingredients for skin, hair, sun protection and color cosmetic products. Its Life Sciences sector comprises three businesses, including Health Care, Crop Protection and Seed Enhancement. Its Performance Technologies sector targets technologies in Smart Materials and Energy Technologies and develops in Home Care & Water. Its Industrial Chemicals sector focuses on developing applications, selling co-streams and undertaking toll processing. The Company operates in Europe, United Kingdom, France, Netherlands, Italy, Spain, Finland, Denmark, Brazil, Argentina, Asia, Singapore, Japan, India, China, Indonesia, Australia and South Africa.
BRIEF: For the fiscal year ended 31 December 2021, Croda International Plc revenues increased 36% to £1.89B. Net income increased 59% to £320.8M. Revenues reflect Life Sciences increase of 43% to £572.3M, Performance Technologies increase of 6% to £439.5M, Industrial Chemicals increase of 19% to £114.8M. Net income benefited from Restructuring Charges/Provisions decrease from £2.9M (expense) to £0K.